Insulin resistance in polycystic ovary syndrome: a systematic review and meta-analysis of euglycaemic–hyperinsulinaemic clamp studies

Cited by (412)

Items 101–200 of 412

1. The Cardiometabolic Risk in Women with Polycystic Ovarian Syndrome (PCOS): From Pathophysiology to Diagnosis and Treatment
   Sotirios Pililis, Stamatios Lampsas, Aikaterini Kountouri, Loukia Pliouta, Emmanouil Korakas, Sarantis Livadas, John Thymis, Μelpomeni Peppa, Sophia Kalantaridou, Evangelos K. Oikonomou et al. · 2024 · Medicina
2. Abdominal Obesity in Women with Polycystic Ovary Syndrome and Its Relationship with Diet, Physical Activity and Insulin Resistance: A Pilot Study
   Jurczewska, Justyna, Ostrowska, Joanna, Chełchowska, Magdalena, Panczyk, Mariusz, Rudnicka, Ewa, Kucharski, Marek, Smolarczyk, Roman, Szostak-Węgierek, Dorota · 2023 · Nutrients
3. Cardiometabolic biomarkers in women with polycystic ovary syndrome
   Kim van der Ham, Yvonne V. Louwers, Joop S.E. Laven · 2022 · Fertility and Sterility
4. PCOS and diabetes mellitus: from insulin resistance to altered beta pancreatic function, a link in evolution
   Rosita Angela Condorelli, Aldo Eugenio Calogero, M. Di Mauro, Sandro La Vignera · 2017 · Gynecological Endocrinology
5. The effect of low glycemic index diet on the reproductive and clinical profile in women with polycystic ovarian syndrome: A systematic review and meta-analysis
   Saadati, Najmieh, Haidari, Fatemeh, Barati, Mojgan, Nikbakht, Roshan, Mirmomeni, Golshan, Rahim, Fakher · 2021 · Heliyon
6. Diagnostic and therapeutic use of oral micronized progesterone in endocrinology
   Eleni Memi, Polina Pavli, Maria Papagianni, Nikolaos Vrachnis, George P. Mastorakos · 2024 · Reviews in Endocrine and Metabolic Disorders
7. Proteomics analysis of potential serum biomarkers for insulin resistance in patients with polycystic ovary syndrome
   Li Li, Jing Zhang, Jing Zeng, Biling Liao, Xiuhong Peng, Tiantian Li, Jieming Li, Qiuxiao Tan, Xiaofang Li, Ying Yang et al. · 2020 · International Journal of Molecular Medicine
8. Diagnosis of disorders of glucose tolerance in women with polycystic ovary syndrome (PCOS) at a tertiary care center: fasting plasma glucose or oral glucose tolerance test?
   A.E. Ortiz-Flores, Manuel Luque‐Ramírez, Elena Fernández‐Durán, Francisco Álvarez‐Blasco, Héctor Francisco Escobar-Morreale · 2019 · Metabolism
9. Prevalence of insulin resistance in Korean women with polycystic ovary syndrome according to various homeostasis model assessment for insulin resistance cutoff values
   Jinju Kim, Kyu Ri Hwang, So Hee Oh, Soo Jin Chae, Sang Ho Yoon, Young Min Choi · 2019 · Fertility and Sterility
10. Short-term effect of beinaglutide combined with metformin versus metformin alone on weight loss and metabolic profiles in obese patients with polycystic ovary syndrome: a pilot randomized trial
    Qing Wen, Song Fang, Yanjing Liang, Yuting Tian, Yiding Chen, Jun Yuan, Chen Qiu · 2023 · Frontiers in Endocrinology
11. Circulating kisspeptin and anti-müllerian hormone levels, and insulin resistance in women with polycystic ovary syndrome: A systematic review, meta-analysis, and meta-regression
    Faustino Ramón Pérez-López, Lía Ornat, María Teresa López-Baena, Javier Santabárbara, Ricardo Savirón‐Cornudella, Gonzalo R. Pérez‐Roncero · 2021 · European Journal of Obstetrics & Gynecology and Reproductive Biology
12. The Effect of Exercise on Cardiometabolic Risk Factors in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis
    Annabelle Breyley-Smith, Aya Mousa, Helena Jane Teede, Nathan A. Johnson, Angelo Sabag · 2022 · International Journal of Environmental Research and Public Health
13. Exploring factors related to changes in body composition, insulin sensitivity and aerobic capacity in response to a 12-week exercise intervention in overweight and obese women with and without polycystic ovary syndrome
    David S. Scott, Cheryce L. Harrison, Samantha K. Hutchison, Barbora Vozarova de Courten, Nigel K. Stepto · 2017 · PLoS ONE
14. Circulating and Adipose Tissue miRNAs in Women With Polycystic Ovary Syndrome and Responses to High-Intensity Interval Training
    Sofie Lionett, Ida Almenning Kiel, DONNY MICHAEL CAMERA, Eszter Vanky, Evelyn B. Parr, Stian Lydersen, John Alan Hawley, Trine Tegdan Moholdt · 2020 · Frontiers in Physiology
15. Circulating irisin in patients with polycystic ovary syndrome: a meta-analysis
    Xue Cai, Shanhu Qiu, Ling Li, Martina Zügel, Jürgen Michael Steinacker, Uwe Schümann · 2017 · Reproductive BioMedicine Online
16. Limitations of insulin resistance assessment in polycystic ovary syndrome
    Krzysztof Cezary Lewandowski, Justyna Płusajska, Wojciech Horzelski, Ewa Bieniek, Andrzej Lewiñski · 2018 · Endocrine Connections
17. High-molecular-weight adiponectin is inversely associated with sympathetic activity in polycystic ovary syndrome
    Soulmaz Shorakae, Sally K. Abell, Danielle Hiam, Élisabeth Lambert, Nina Eikelis, Eveline Jona, Carolina Ika Sari, Nigel K. Stepto, Gavin William Lambert, Barbora Vozarova de Courten et al. · 2018 · Fertility and Sterility
18. Insulin-Mediated Substrate Use in Women With Different Phenotypes of PCOS: the Role of Androgens
    Flavia Tosi, Michela Villani, Matteo Migazzi, Giulia Faccin, Sabrina Garofalo, Tom Fiers, Jean‐Marc Kaufman, Enzo Bonora, Paolo Moghetti · 2021 · The Journal of Clinical Endocrinology & Metabolism
19. Obesity and the Risk of Infertility, Gestational Diabetes, and Type 2 Diabetes in Polycystic Ovary Syndrome
    Pirotta, Stephanie, Joham, Anju, Grieger, Jessica A., Tay, Chau Tien, Bahri-Khomami, Mahnaz, Lujan, Marla, Lim, Siew S., Moran, Lisa J. · 2020 · Seminars in Reproductive Medicine
20. Metabolic inflexibility in women with polycystic ovary syndrome: a systematic review
    Rimmer, Michael, Tan, Bee K., Teede, Helena, Thangaratinam, Shakila, H. Al Wattar, Bassel · 2020 · Gynecological Endocrinology
21. AGEs-related dysfunctions in PCOS: evidence from animal and clinical research
    Carla Tatone, Giovanna Di Emidio, Martina Placidi, Giulia Rossi, Stefania Ruggieri, Chiara Taccaliti, Angela D’Alfonso, Fernanda Amicarelli, Maurizio Guido · 2021 · Journal of Endocrinology
22. RETRACTED: Effects of N-acetylcysteine and metformin treatment on the stereopathological characteristics of uterus and ovary
    Bahare Rafiee, Saied Karbalay‐Doust, Kaoru Tabei, Negar Azarpira, Sanaz Alaee, Parvin Lohrasbi, Soghra Bahmanpour · 2022 · European Journal of Translational Myology · Retracted
23. Prevalence, pathogenesis and management of prediabetes and type 2 diabetes mellitus in patients with polycystic ovary syndrome
    Sofia Lazaridou, K. Dinas, K. Tziomalos · 2017 · HORMONES
24. Neurokinin 3 Receptor Antagonism Ameliorates Key Metabolic Features in a Hyperandrogenic PCOS Mouse Model
    Irene E Sucquart, Ruchi Nagarkar, Melissa C Edwards, Valentina Rodriguez Paris, Ali Aflatounian, Michael J. Bertoldo, Rebecca E. Campbell, Robert Bruce Gilchrist, Denovan P. Begg, David J. Handelsman et al. · 2021 · Endocrinology
25. A PCOS Paradox: Does Inositol Therapy Find a Rationale in All the Different Phenotypes?
    Vittorio Unfer, Simona Dinicola, Michele Russo · 2023 · International Journal of Molecular Sciences
26. Bisphenol a downregulates GLUT4 expression by activating aryl hydrocarbon receptor to exacerbate polycystic ovary syndrome
    Jing Shi, Kai-Lun Hu, Xiaoxue Li, Yimeng Ge, Yu Xiaojun, Jie Zhao · 2024 · Cell Communication and Signaling
27. Gonadal dysfunction in women with diabetes mellitus
    Maria Zaimi, Olympia Michalopoulou, Katerina Stefanaki, Paraskevi Kazakou, Vasiliki Vasileiou, Θεοδώρα Ψαλτοπούλου, Dimitrios S. Karagiannakis, Stavroula Α. Paschou · 2024 · Endocrine
28. Incretin Hormone Secretion in Women with Polycystic Ovary Syndrome: Roles of Obesity, Insulin Sensitivity and Treatment with Metformin and GLP-1s
    Andrea Etrusco, Mislav Mikuš, Antonio D’Amato, Fabio Barra, Petar Planinić, Trpimir Goluža, Giovanni Buzzaccarini, Jelena Marušić, Mara Tešanović, Antonio Simone Laganà · 2024 · Biomedicines
29. Biomarkers in polycystic ovary syndrome
    Alexandra M Huffman, Samar Rezq, Jelina Basnet, Damián G. Romero · 2023 · Current Opinion in Physiology
30. Characteristics and possible mechanisms of metabolic disorder in overweight women with polycystic ovary syndrome
    Jin Yu, Yulai Zhou, Jie Ding, Danying Zhang, Chaoqin Yu, Hefeng Huang · 2023 · Frontiers in Endocrinology
31. Risk of Type 2 Diabetes, MASLD and Cardiovascular Disease in People Living With Polycystic Ovary Syndrome
    Alex E. Henney, Conor S Gillespiec, J LAI, Pietá Schofield, David R. J. Riley, Rishi Caleyachetty, Thomas M. Barber, Alexander Dimitri Miras, Laurence J. Dobbie, David Michael Hughes et al. · 2024 · The Journal of Clinical Endocrinology & Metabolism
32. Dynamic Change in Insulin Resistance Induced by Free Fatty Acids Is Unchanged Though Insulin Sensitivity Improves Following Endurance Exercise in PCOS
    Myint Myint Aye, Alexandra E. Butler, Eric S. Kilpatrick, Richard Kirk, Rebecca V. Vince, Alan S. Rigby, Derek D. Sandeman, Stephen Lawrence Atkin · 2018 · Frontiers in Endocrinology
33. Women undergoing assisted fertilisation and high-intensity interval training: a pilot randomised controlled trial
    Ida Almenning Kiel, Kari Lundgren, Siv Mørkved, Sigrun Kjøtrød, Øyvind Olav Salvesen, Liv Bente Romundstad, Trine Tegdan Moholdt · 2018 · BMJ Open Sport & Exercise Medicine
34. Acupuncture combined with metformin versus metformin alone to improve pregnancy rate in polycystic ovary syndrome: A systematic review and meta-analysis
    Xin Chen, Ying Lan, Lijie Yang, Yang Liu, Hongyu Li, Xinyun Zhu, Yuemeng Zhao, Caiyi Long, Mengjing Wang, Qingling Xie et al. · 2022 · Frontiers in Endocrinology
35. Metabolic inflexibility in women with PCOS is similar to women with type 2 diabetes
    Nicholas T. Broskey, Charmaine S. Tam, Elizabeth F. Sutton, Abby D. Altazan, Jeffrey H. Burton, Éric Ravussin, Leanne Maree Redman · 2018 · Nutrition & Metabolism
36. Update on the therapeutic role of metformin in the management of polycystic ovary syndrome: Effects on pathophysiologic process and fertility outcomes
    Kerstin M.G. Brand, Ulrike Gottwald‐Hostalek, Aimee Andag‐Silva · 2025 · Women s Health
37. Role of polyphenols in remodeling the host gut microbiota in polycystic ovary syndrome
    Ping Zhou, Penghui Feng, Baoying Liao, Lin Na Fu, Hongying Shan, Canhui Cao, Renxin Luo, Tianliu Peng, Fen-Ting Liu, Rong Li · 2024 · Journal of Ovarian Research
38. Prospective risk of Type 2 diabetes in 99 892 Nordic women with polycystic ovary syndrome and 446 055 controls: national cohort study from Denmark, Finland, and Sweden
    Dorte Glintborg, Meri‐Maija Ollila, Jens‐Jakob Kjer Møller, Paula Pesonen, Sofia Persson, Evangelia Elenis, Katrine Hass Rubin, Mika Gissler, Marianne Andersen, Inger Sundström Poromaa et al. · 2024 · Human Reproduction
39. No impact of gestational diabetes mellitus on pregnancy complications in women with PCOS, regardless of GDM criteria used
    Fougner, Stine Lyngvi, Vanky, Eszter, Løvvik, Tone Shetelig, Carlsen, Sven Magnus · 2021 · PLOS ONE
40. The effectiveness of high intensity intermittent training on metabolic, reproductive and mental health in women with polycystic ovary syndrome: study protocol for the iHIT- randomised controlled trial
    Danielle Hiam, Rhiannon Kate Patten, Melanie E. Gibson‐Helm, Alba Moreno‐Asso, Luke C. McIlvenna, Itamar Levinger, Cheryce L. Harrison, Lisa Moran, Anju Elizabeth Joham, Alexandra G. Parker et al. · 2019 · Trials
41. A prospective pilot study of the effect of acupuncture on insulin sensitivity in women with polycystic ovary syndrome and insulin resistance
    Juan Li, Wanting Wu, Elisabet Stener‐Victorin, Ernest Hung Yu Ng, Raymond Li, Meifang Li, Hua Liu, Maohua Lai, Yanbing Meng, Yanhua Zheng et al. · 2020 · Acupuncture in Medicine
42. Hyperandrogenism and anthropometric parameters in women with polycystic ovary syndrome
    Asieh Mansour, Maryam Noori, Monir Sadat Hakemi, Ziba Haghgooyan, Mohammad Reza Mohajeri‐Tehrani, Maryam Mirahmad, Sayed Mahmoud Sajjadi‐Jazi · 2024 · BMC Endocrine Disorders
43. Prediction of Insulin Resistance and Impaired Fasting Glucose Based on Sex Hormone-Binding Globulin (SHBG) Levels in Polycystic Ovary Syndrome
    Aleksandra Biernacka-Bartnik, Piotr Kocełak, Aleksander Jerzy Owczarek, Piotr Stanisław Choręza, Monika Puzianowska‐Kuźnicka, Leszek Markuszewski, Paweł Madej, Jerzy Tadeusz Chudek, Magdalena Olszanecka‐Glinianowicz · 2022 · International Journal of Endocrinology
44. Insights into Vitamin E with Combined Oral Contraceptive on INSR Gene in PCOS by Integrating In Silico and In Vivo Approaches
    Rukaiah Fatma Begum, Sumithra Mohan · 2023 · Applied Biochemistry and Biotechnology
45. A review of metabolic and microbial influences on women with polycystic ovarian syndrome
    Foram K. Ravat, Janki Goswami, Sneha M Nair, Kashyap N. Thummar · 2024 · Steroids
46. Metabolic characteristics and adverse pregnancy outcomes for women with hyperglycaemia in pregnancy as a function of insulin resistance
    Emmanuel Cosson, Charlotte Nachtergaele, Éric Vicaut, Sopio Tatulashvili, Meriem Sal, Narimane Berkane, Sara Pinto, Emmanuelle E. Fabre, Amélie Benbara, Marion Fermaut et al. · 2022 · Diabetes & Metabolism
47. Assessment of Type 2 Diabetes Risk in Young Women with Polycystic Ovary Syndrome
    Sarantis Livadas, Rodis D. Paparodis, Panagiotis G. Anagnostis, Alessandra Gambineri, Djuro Μacut, Tijana Petrović, Bülent Okan Yıldız, Dragan Micić, George P. Mastorakos, Djuro Μacut · 2023 · Diagnostics
48. Effects of high-protein diets on the cardiometabolic factors and reproductive hormones of women with polycystic ovary syndrome: a systematic review and meta-analysis
    Wang, Fang, Dou, Pan, Wei, Wei, Liu, Peng Ju · 2024 · Nutrition & Diabetes
49. Current treatment for polycystic ovary syndrome: focus on adolescence
    Maria Elisabeth Street, Francesca Cirillo, Cecilia Catellani, Marco Dauriz, Pietro Lazzeroni, Chiara Sartori, Paolo Moghetti · 2020 · Minerva Pediatrics
50. Elucidating the role of pigment epithelium-derived factor (PEDF) in metabolic PCOS models
    Michal Silber, Irit Miller, Hadas Bar‐Joseph, Ido Ben‐Ami, Ruth Shalgi · 2019 · Journal of Endocrinology
51. Weight Management Strategies to Reduce Metabolic Morbidity in Women With Polycystic Ovary Syndrome
    Michail Diakosavvas, Oyinlola O Oyebode, Priya Bhide · 2025 · Current Obesity Reports
52. POLYCYSTIC OVARY SYNDROME: ORIGINS AND IMPLICATIONS: The impact of polycystic ovary syndrome on reproductive health: a narrative review
    Lisa Ann Owens, Stephen Franks · 2025 · Reproduction
53. HIIT'ing or MISS'ing the Optimal Management of Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis of High- Versus Moderate-Intensity Exercise Prescription
    Cory T. Richards, Victoria L. Meah, Philip Eurig James, Aled Rees, Rachel N. Lord · 2021 · Frontiers in Physiology
54. Pregnancy urinary concentrations of bisphenol A, parabens and other phenols in relation to serum levels of lipid biomarkers: Results from the EARTH study
    Lidia Mínguez‐Alarcón, Lisa Frueh, Paige L. Williams, Tamarra M James-Todd, Irene C. Souter, Jennifer B. Ford, Kathryn M. Rexrode, Antonia M. Calafat, Russ B. Hauser, Jorge E. Chavarro · 2022 · The Science of The Total Environment
55. Reducing the Risk of Pre-Eclampsia in Women with Polycystic Ovary Syndrome Using a Combination of Pregnancy Screening, Lifestyle, and Medical Management Strategies
    Jim Parker, Claire Louise O'Brien, Christabelle Yeoh, Felice L Gersh, Shaun Patrick Brennecke · 2024 · Journal of Clinical Medicine
56. The Relationship Between Polycystic Ovarian Syndrome, Periodontal Disease, and Osteoporosis
    Hannah E. Young, Wendy Elizabeth Ward · 2020 · Reproductive Sciences
57. Nutritional support and dietary interventions for women with polycystic ovary syndrome
    Kleopatra Papavasiliou, Emilia Papakonstantinou · 2017 · Nutrition and Dietary Supplements
58. Adipose-androgen crosstalk in polycystic ovary syndrome: mechanisms and therapeutic implications
    Muchu Ni, Hongyan Lei, Tao Ye, Yongzhou Wang · 2025 · Frontiers in Endocrinology
59. Key signalling pathways underlying the aetiology of polycystic ovary syndrome
    Kirsty A. Walters, Alba Moreno-Asso, Nigel K. Stepto, Michaël W. Pankhurst, Valentina Rodriguez Paris, Raymond Joseph Rodgers · 2022 · Journal of Endocrinology
60. Glucose Homeostasis, Diabetes Mellitus, and Gender-Affirming Treatment
    Charalampos Milionis, Ιoannis Ilias, Evangelia Venaki, Eftychia Koukkou · 2023 · Biomedicines
61. The Effects of Myo-Inositol and D-Chiro-Inositol in a Ratio 40:1 on Hormonal and Metabolic Profile in Women with Polycystic Ovary Syndrome Classified as Phenotype A by the Rotterdam Criteria and EMS-Type 1 by the EGOI Criteria
    Olga A. Pustotina, Samuel Harry Myers, Vittorio Unfer, Irina Rasulova · 2024 · Gynecologic and Obstetric Investigation
62. Associations of Vitamin D with Inter- and Intra-Muscular Adipose Tissue and Insulin Resistance in Women with and without Polycystic Ovary Syndrome
    David S. Scott, Anju Elizabeth Joham, Helena Jane Teede, Melanie E. Gibson‐Helm, Cheryce L. Harrison, Samantha Cassar, Samantha K. Hutchison, Peter Robert Ebeling, Nigel K. Stepto, Barbora Vozarova de Courten · 2016 · Nutrients
63. Determination of insulin resistance and its relationship with hyperandrogenemia,anti-Müllerian hormone, inhibin A, inhibin B, and insulin-like peptide-3 levels in adolescent girls with polycystic ovary syndrome
    Aylin Yetim, Firdevs Baş, Çağcıl Yetim, Ahmet Uçar, Şükran Poyrazoğlu, Rüveyde Bundak, Feyza Darendelıler · 2019 · TURKISH JOURNAL OF MEDICAL SCIENCES
64. Moving beyond Weight: A Narrative Review of the Dietary and Lifestyle Management for Reducing Cardiometabolic Risk in Polycystic Ovary Syndrome (PCOS)
    Herbert, Shannon, Woolf, Kathleen · 2023 · Nutrients
65. The Role of Diet, Glycaemic Index and Glucose Control in Polycystic Ovary Syndrome (PCOS) Management and Mechanisms of Progression
    Claire Johnson, Gökçen Garipoğlu, Yvonne Jeanes, Giada Frontino, Adele Costabile · 2025 · Current Nutrition Reports
66. Metformin in gynecological disorders: pathogenic insights and therapeutic implications
    Ping Nie, Minghua Wang, Yan Mo, Hong Zhou, Qingbing Zha, Gendie E. Lash, Ping Li · 2025 · Frontiers in Pharmacology
67. POLYCYSTIC OVARY SYNDROME: ORIGINS AND IMPLICATIONS: Polycystic ovary syndrome: the impact of androgen excess on metabolic health
    Leanne Cussen, Tara McDonnell, Clare Miller, Marie McIlroy, Michael O’Reilly · 2025 · Reproduction
68. Polyamines in Ovarian Aging and Disease
    Bo Kang, Xin Wang, Xiaoguang An, Chengweng Ji, Weikang Ling, Yuxin Qi, Shuo Li, Dongmei Jiang · 2023 · International Journal of Molecular Sciences
69. Improving reproductive function in women with polycystic ovary syndrome with high-intensity interval training (IMPROV-IT): study protocol for a two-centre, three-armed randomised controlled trial
    Ida Almenning Kiel, Sofie Lionett, Evelyn B. Parr, Helen Jones, Maria Aurora Røset, Øyvind Olav Salvesen, Eszter Vanky, Trine Tegdan Moholdt · 2020 · BMJ Open
70. Adiponectin and leptin levels in normal weight women with polycystic ovary syndrome
    Murat Gözüküçük, Aslı Yarcı Gürsoy, Emre Destegül, Salih Taşkın, Hakan Şatıroğlu · 2020 · Hormone Molecular Biology and Clinical Investigation
71. [Retracted] Predicting Risk of Insulin Resistance in a Chinese Population with Polycystic Ovary Syndrome: Designing and Testing a New Predictive Nomogram
    Feng Jiang, Ke Wei, Wenjun Lyu · 2020 · BioMed Research International · Retracted
72. Association of Urinary Phthalate and Phthalate Replacement Metabolite Concentrations with Serum Lipid Biomarker Levels among Pregnant Women Attending a Fertility Center
    Lidia Mínguez‐Alarcón, Paige L. Williams, Tamarra M James-Todd, Irene C. Souter, Jennifer B. Ford, Kathryn M. Rexrode, Antonia M. Calafat, Russ B. Hauser, Jorge E. Chavarro · 2022 · Toxics
73. Can resistance training improve the symptoms of polycystic ovary syndrome?
    Paraskevi Pericleous, Savvas Stephanides · 2018 · BMJ Open Sport & Exercise Medicine
74. Impact of Polycystic Ovary Syndrome on Silent Coronary Artery Disease and Cardiovascular Events; A Long-term Population-based Cohort Study
    Fatemeh Mahboobifard, Maryam Rahmati, Atrin Niknam, Ehsan Rojhani, Amir Abbas Momenan, Fereidoun Azizi, Fahimeh Ramezani Tehrani · 2021 · Archives of Medical Research
75. AMPK Activation as a Protective Mechanism to Restrain Oxidative Stress in the Insulin-Resistant State in Skeletal Muscle of Rat Model of PCOS Subjected to Postnatal Overfeeding
    Bojana Mićić, Ana D. Djordjevic, Nataša A. Veličković, Sanja Kovačević, Teodora Martić, Djuro Μacut, Danijela Vojnović Milutinović · 2023 · Biomedicines
76. Fisetin ameliorates polycystic ovary syndrome in rats via a mechanistic modulation of AMP-activated protein kinase and SIRT1 molecular pathway
    Simerjeet Kaur Chahal, Atul Kabra · 2024 · Naunyn-Schmiedeberg s Archives of Pharmacology
77. Changes in Metabolic Profile in the Women with a History of PCOS—A Long-Term Follow-Up Study
    Małgorzata Jacewicz‐Święcka, Irina Kowalska · 2020 · Journal of Clinical Medicine
78. A review of audiovisual telemedicine utilization and satisfaction assessment during the COVID-19 pandemic
    Raphael Agbali, Andrew E. Balas, Francesco Beltrame, Gianluca De Leo · 2021 · International Journal of Technology Assessment in Health Care
79. Treatment with Myo-Inositol Does Not Improve the Clinical Features in All PCOS Phenotypes
    Vittorio Unfer, Michele Russo, Cesare Aragona, Gabriele Bilotta, Mario Montanino Oliva, Mariano Bizzarri · 2023 · Biomedicines
80. Recognizing the Role of Insulin Resistance in Polycystic Ovary Syndrome: A Paradigm Shift from a Glucose-Centric Approach to an Insulin-Centric Model
    Jim Parker, Lara Briden, Felice L Gersh · 2025 · Journal of Clinical Medicine
81. POLYCYSTIC OVARY SYNDROME: ORIGINS AND IMPLICATIONS: Epidemiological aspects of polycystic ovary syndrome
    Anju Elizabeth Joham, Aled Rees, Kanade Shinkai, Maria Forslund, Chau Thien Tay, Helena Jane Teede · 2025 · Reproduction
82. Anthropometric, Metabolic, and Endocrine Parameters as Predictors of Estimated Average Glucose and Other Biomarkers of Dysglycemia in Women with Different Phenotypes of Polycystic Ovary Syndrome
    Sebastião Freitas de Medeiros, Ana Karine Lin Winck Yamamoto de Medeiros, Matheus Antônio Souto de Medeiros, Anna Bethany da Silva Carvalho, Márcia MW Yamamoto, José Maria Soares, Edmund Chada Baracat · 2023 · Hormone and Metabolic Research
83. IMPROVE lifestyle in polycystic ovary syndrome: a systematic strategy
    Lino Del Pup, Angelo Cagnacci · 2021 · Gynecological Endocrinology
84. Characterizing skeletal muscle dysfunction in women with polycystic ovary syndrome
    Tara McDonnell, Leanne Cussen, Marie McIlroy, Michael O’Reilly · 2022 · Therapeutic Advances in Endocrinology and Metabolism
85. Therapy of obesity in women with PCOS using GLP-1 analogues — benefits and limitations [Terapia otyłości u kobiet z PCOS przy zastosowaniu analogów GLP-1 — korzyści i ograniczenia]
    Agnieszka Baranowska-Bik · 2022 · Endokrynologia Polska
86. Polycystic Ovary Syndrome: A Brief Review with Recent Updates
    Shahana Shermin, Aysha Noor, Samsad Jahan · 2020 · Delta Medical College Journal
87. Functional hypothalamic amenorrhea with or without polycystic ovarian morphology: a retrospective cohort study about insulin resistance
    Daniel Mayrhofer, Didier Dewailly, Marlene Hager · 2022 · Fertility and Sterility
88. Potential Roles of mtDNA Mutations in PCOS-IR: A Review
    Xiaochao Dong, Chang Liu, Guangchao Zhuo, Yu Ding · 2023 · Diabetes Metabolic Syndrome and Obesity
89. Change in Androgenic Status and Cardiometabolic Profile of Middle-Aged Women with Polycystic Ovary Syndrome
    Kim van der Ham, Maria P. H. Koster, Birgitta K. Velthuis, Ricardo P.J. Budde, Bart C.J.M. Fauser, Joop S.E. Laven, Yvonne V. Louwers · 2023 · Journal of Clinical Medicine
90. Ampelopsis japonica aqueous extract improves ovulatory dysfunction in PCOS by modulating lipid metabolism
    Huiqing Zhu, Yuanyuan Wu, Ziming Zhuang · 2023 · Biomedicine & Pharmacotherapy
91. Nutritional and exercise interventions to improve conception in women suffering from obesity and distinct nosological entities
    Evdoxia Gitsi, Sarantis Livadas, Georgia Argyrakopoulou · 2024 · Frontiers in Endocrinology
92. The Impact of Intra-articular Depot Betamethasone Injection on Insulin Resistance Among Diabetic Patients With Osteoarthritis of the Knee
    George S. Habib, Mark Chernin, Fahed Sakas · 2017 · JCR Journal of Clinical Rheumatology
93. The potential role of the Mediterranean Diet for the treatment and management of Polycystic Ovary Syndrome: a review of the pathophysiological mechanisms and clinical evidence.
    Scannell, Nicole, Villani, Anthony, Moran, Lisa, Mantzioris, Evangeline · 2025 · Proceedings of the Nutrition Society
94. Treatment of polycystic ovary syndrome and its associated psychiatric symptoms with the Mongolian medicine Nuangong Qiwei Pill and macelignan
    Xiaojie Shi, Yang Du, Lei Chen, Yuanyuan Chen, Man Luo, Yong Cheng · 2023 · Journal of Ethnopharmacology
95. Is polycystic ovary syndrome associated with elevated muscle sympathetic nerve activity?
    Alicia Duval, Will Huckins, Danielle E. Berbrier · 2023 · Experimental Physiology
96. Effects of immune cells and cytokines on the endometrial immune microenvironment in polycystic ovary syndrome
    Zhenhong Ye, Jie Zhao, Rong Li · 2022 · Gynecology and Obstetrics Clinical Medicine
97. Insulin Resistance: An Update on Biochemical and Pathophysiological Mechanisms and Impact on Various Diseases
    Peter J. Little, Stefan Offermanns, Haaglim Cho, Zhiping Liu, Pinglian Yang, Qiaozhu Su, Henry Wade, Wah Yang, Danielle Kamato, Neale D. Cohen et al. · 2026 · iNew Medicine
98. Comparative effects of acupuncture and metformin on insulin sensitivity in overweight/obese and lean women with polycystic ovary syndrome and insulin resistance: a post hoc analysis of a randomized trial
    Jie Cao, GuanHua Nie, Zhihao Dai, Dan Shan, Zhihong Wei · 2023 · Frontiers in Medicine
99. The association between triglyceride-glucose index and polycystic ovary syndrome: a systematic review and meta-analysis across different populations
    Amin Javidan, Alireza Azarboo, Sayeh Jalali, Parisa Fallahtafti, Shabboo Moayyed, Marjan Ghaemi, Azadeh Tarafdari, Sedigheh Hantoushzadeh · 2025 · Journal of Ovarian Research
100. Association of polycystic ovary syndrome with atherosclerotic cardiovascular disease events
     Iris TIENLYNN. Lee, Anuja Dokras, Snigdha Alur-Gupta · 2025 · Fertility and Sterility